{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:16:06Z","timestamp":1788189366641,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010234","name":"Asthma and Allergy Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010234","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"The Swedish Heart Lung Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006706","name":"Tampere Tuberculosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jacig.2026.100739","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:41:10Z","timestamp":1780332070000},"page":"100739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fractional exhaled nitric oxide and blood eosinophils in relation to lung function, allergy and nasal polyps in asthma"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2803-2912","authenticated-orcid":false,"given":"Reshed","family":"Abohalaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri","family":"Lehtim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selin","family":"Ercan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniil","family":"Lisik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saliha Selin","family":"\u00d6zuygur Ermis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinja","family":"Ilmarinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teet","family":"Pullerits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Backman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"R\u00e5dinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bright I.","family":"Nwaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannu","family":"Kankaanranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacig.2026.100739_bib1","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jaip.2020.09.051","article-title":"The prevalence of subtypes of type 2 inflammation in an unselected population of patients with severe asthma","volume":"9","author":"Fr\u00f8ssing","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2026.100739_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13601-019-0282-7","article-title":"Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations","volume":"9","author":"Price","year":"2019","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jacig.2026.100739_bib3","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.jaci.2016.01.044","article-title":"Simultaneously increased fraction of exhaled nitric oxide levels and blood eosinophil counts relate to increased asthma morbidity","volume":"138","author":"Malinovschi","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2026.100739_bib4","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaip.2023.01.008","article-title":"Toward a predict and prevent approach in obstructive airway diseases","volume":"11","author":"Couillard","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2026.100739_bib5","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02536-2017","article-title":"Associations between blood eosinophils and decline in lung function among adults with and without asthma","volume":"51","author":"Hancox","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacig.2026.100739_bib6","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1164\/rccm.202104-1040LE","article-title":"Fractional exhaled nitric oxide nonsuppression identifies corticosteroid-resistant type 2 signaling in severe asthma","volume":"204","author":"Couillard","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacig.2026.100739_bib7","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1365-2222.2008.02969.x","article-title":"IL-13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells","volume":"38","author":"Chibana","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jacig.2026.100739_bib8","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacig.2026.100739_bib9","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","article-title":"Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial","volume":"380","author":"Pavord","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jacig.2026.100739_bib10","unstructured":"GINA. Global strategy for asthma management and prevention, 2024. Report no. 2024. Available at: https:\/\/ginasthma.org\/wp-content\/uploads\/2024\/05\/GINA-2024-Strategy-Report-24_05_22_WMS.pdf. Accessed August 23, 2025."},{"key":"10.1016\/j.jacig.2026.100739_bib11","article-title":"Blood eosinophil reference values and determinants in a representative adult population","volume":"4","author":"Abohalaka","year":"2025","journal-title":"J Allergy Clin Immunol Glob"},{"key":"10.1016\/j.jacig.2026.100739_bib12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/resp.14294","article-title":"Sub-stratification of type-2 high airway disease for therapeutic decision-making: a \u2018bomb\u2019 (blood eosinophils) meets 'magnet' (FeNO) framework","volume":"27","author":"Couillard","year":"2022","journal-title":"Respirology"},{"key":"10.1016\/j.jacig.2026.100739_bib13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jaci.2013.06.007","article-title":"Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and Nutrition Examination Survey subjects","volume":"132","author":"Malinovschi","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2026.100739_bib14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/thoraxjnl-2021-217325","article-title":"Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide","volume":"77","author":"Couillard","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.jacig.2026.100739_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-027808","article-title":"Cohort profile: the West Sweden Asthma Study (WSAS): a multidisciplinary population-based longitudinal study of asthma, allergy and respiratory conditions in adults","volume":"9","author":"Nwaru","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacig.2026.100739_bib16","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/all.70106","article-title":"Asthma remission in adults: role of age at asthma onset, smoking, obesity, and allergic rhinitis","volume":"81","author":"Abohalaka","year":"2026","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2026.100739_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.70160","article-title":"Adult-onset compared to childhood-onset asthma: multifaceted symptoms, comorbidity, and healthcare burden","volume":"16","author":"Abohalaka","year":"2026","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jacig.2026.100739_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.70015","article-title":"Lifetime asthma incidence is related to age at onset and allergies in western Sweden","volume":"14","author":"Abohalaka","year":"2024","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jacig.2026.100739_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-20657-8","article-title":"Obesity and weight change during eight years in relation to asthma incidence","volume":"15","author":"Abohalaka","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacig.2026.100739_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.70107","article-title":"Reference values and determinants of fractional exhaled nitric oxide in a representative adult population in Western Sweden","volume":"15","author":"Abohalaka","year":"2025","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jacig.2026.100739_bib21","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1164\/rccm.200406-710ST","article-title":"ATS\/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005","volume":"171","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacig.2026.100739_bib22","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00965-2016","article-title":"A European Respiratory Society technical standard: exhaled biomarkers in lung disease","volume":"49","author":"Horv\u00e1th","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacig.2026.100739_bib23","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society Technical Statement","volume":"200","author":"Graham","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacig.2026.100739_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacig.2026.100739_bib25","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacig.2026.100739_bib26","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00838-2020","article-title":"High eosinophil counts predict decline in FEV1: results from the CanCOLD study","volume":"57","author":"Tan","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacig.2026.100739_bib27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/thorax-2023-220972","article-title":"Type-2 inflammation and lung function decline in chronic airway disease in the general population","volume":"79","author":"\u00c7olak","year":"2024","journal-title":"Thorax"},{"key":"10.1016\/j.jacig.2026.100739_bib28","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01785-2017","article-title":"Predictors of accelerated decline in lung function in adult-onset asthma","volume":"51","author":"Coumou","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacig.2026.100739_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100110","article-title":"FEV(1) decline in relation to blood eosinophils and neutrophils in a population-based asthma cohort","volume":"13","author":"Backman","year":"2020","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jacig.2026.100739_bib30","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jaip.2020.07.055","article-title":"Blood eosinophil count as a predictor of lung function decline in healthy individuals","volume":"9","author":"Lee","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2026.100739_bib31","doi-asserted-by":"crossref","first-page":"00368","DOI":"10.1183\/23120541.00368-2025","article-title":"Longitudinal variability of blood eosinophils impact lung function decline in the general population","volume":"11","author":"Lim","year":"2025","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jacig.2026.100739_bib32","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.alit.2015.12.006","article-title":"Persistently high exhaled nitric oxide and loss of lung function in controlled asthma","volume":"65","author":"Matsunaga","year":"2016","journal-title":"Allergol Int"},{"key":"10.1016\/j.jacig.2026.100739_bib33","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1183\/09031936.00135907","article-title":"Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma","volume":"32","author":"van Veen","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacig.2026.100739_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2021.100544","article-title":"Bronchodilator response and lung function decline: associations with exhaled nitric oxide with regard to sex and smoking status","volume":"14","author":"Nerpin","year":"2021","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jacig.2026.100739_bib35","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FeNO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacig.2026.100739_bib36","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2500\/aap.2009.30.3253","article-title":"Evaluation of airway hyperresponsiveness and exhaled nitric oxide as risk factors for airway remodeling in patients with stable asthma","volume":"30","author":"Ohkura","year":"2009","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jacig.2026.100739_bib37","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jaip.2018.03.004","article-title":"Type 2 biomarkers and prediction of future exacerbations and lung function decline in adult asthma","volume":"6","author":"Semprini","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2026.100739_bib38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00408-024-00760-9","article-title":"Increase in blood eosinophil count over time and sputum IL8 are associated with FEV(1) decline in asthma","volume":"203","author":"Graff","year":"2024","journal-title":"Lung"},{"key":"10.1016\/j.jacig.2026.100739_bib39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.rmed.2019.04.017","article-title":"Association between exhaled nitric oxide and nasal polyposis in severe asthma","volume":"152","author":"Maniscalco","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.jacig.2026.100739_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2025.107940","article-title":"The impact of blood eosinophil count and FeNO on benralizumab effectiveness in clinical practice: an ORBE II subanalysis","volume":"237","author":"Garc\u00eda-Moguel","year":"2025","journal-title":"Respir Med"},{"key":"10.1016\/j.jacig.2026.100739_bib41","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jama.2015.19330","article-title":"Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial","volume":"315","author":"Bachert","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jacig.2026.100739_bib42","doi-asserted-by":"crossref","first-page":"00483","DOI":"10.1183\/23120541.00483-2022","article-title":"Distribution of type 2 biomarkers and association with severity, clinical characteristics and comorbidities in the BREATHE real-life asthma population","volume":"9","author":"Fr\u00f8ssing","year":"2023","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jacig.2026.100739_bib43","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1164\/rccm.201903-0599LE","article-title":"Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide, and their combination in severe asthma: a post hoc analysis","volume":"200","author":"Shrimanker","year":"2019","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829326001013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829326001013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:24:56Z","timestamp":1788186296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772829326001013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2772829326001013"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2026.100739","relation":{},"ISSN":["2772-8293"],"issn-type":[{"value":"2772-8293","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fractional exhaled nitric oxide and blood eosinophils in relation to lung function, allergy and nasal polyps in asthma","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2026.100739","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100739"}}